Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-04-28

Clinical Trial Update: A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on Andrographolide Sulfonate for acute exacerbation of chronic bronchitis; the current study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Andrographolide Sulfonate (andrographolide sulfonate)

Snippet

Sponsor: Jiangxi Qingfeng Pharmaceutical Co. Ltd. | Conditions: Acute Exacerbation of Chronic Bronchitis | Phase 4 | Status: UNKNOWN